Xvivo Perfusion AB
STO:XVIVO
Xvivo Perfusion AB
Research & Development
Xvivo Perfusion AB
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Xvivo Perfusion AB
STO:XVIVO
|
Research & Development
-kr103.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-21%
|
|
Bactiguard Holding AB
STO:BACTI B
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Xvivo Perfusion AB's Research & Development?
Research & Development
-103.8m
SEK
Based on the financial report for Mar 31, 2024, Xvivo Perfusion AB's Research & Development amounts to -103.8m SEK.
What is Xvivo Perfusion AB's Research & Development growth rate?
Research & Development CAGR 10Y
-21%
Over the last year, the Research & Development growth was -40%.